Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antitumour activity of a combined treatment with PMEDAP and docetaxel in the Prague inbred Sprague-Dawley/cub rat strain bearing T-cell lymphoma

K. Bobkov, I. Gut, V. Mandys, A. Holy, I. Votruba, B. Otova

. 2001 ; 21 (4A) : 2725-2731.

Jazyk angličtina Země Řecko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13012309

Grantová podpora
NL5423 MZ0 CEP - Centrální evidence projektů

Antitumour efficiency of combined therapy with N-9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP) and docetaxel (DTX) was studied in an in vivo model of s.c. transplanted Sprague-Dawley (SD/Cub) rat T-cell lymphoma (phenotype SD10/96). The effect of the combined treatment of DTX with PMEDAP was significantly higher than that of DTX or PMEDAP alone. The s.c. administration of DXT into the vicinity of growing lymphoma together with i.p. administration of PMEDAP was found to be the most efficient combination. In this case, two out of four rats did not develop any lymphoma and remained alive. An irregular expression of Bcl2 protein was found in untreated and treated lymphomas, while the expression of protein p53 as well as MDM2 was not observed. All three types of the above-mentioned treatments (PMEDAP, DXT, DXT+PMEDAP) increased significantly the number of p21-positive cells, compared with untreated tumours.

000      
00000naa a2200000 a 4500
001      
bmc13012309
003      
CZ-PrNML
005      
20130405113827.0
007      
ta
008      
130405s2001 gr f 000 0|eng||
009      
AR
035    __
$a (PubMed)11724347
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a gr
100    1_
$a Bobková, Klára, $d 1969- $7 xx0256907 $u Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Prague, Czech Republic.
245    10
$a Antitumour activity of a combined treatment with PMEDAP and docetaxel in the Prague inbred Sprague-Dawley/cub rat strain bearing T-cell lymphoma / $c K. Bobkov, I. Gut, V. Mandys, A. Holy, I. Votruba, B. Otova
520    9_
$a Antitumour efficiency of combined therapy with N-9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP) and docetaxel (DTX) was studied in an in vivo model of s.c. transplanted Sprague-Dawley (SD/Cub) rat T-cell lymphoma (phenotype SD10/96). The effect of the combined treatment of DTX with PMEDAP was significantly higher than that of DTX or PMEDAP alone. The s.c. administration of DXT into the vicinity of growing lymphoma together with i.p. administration of PMEDAP was found to be the most efficient combination. In this case, two out of four rats did not develop any lymphoma and remained alive. An irregular expression of Bcl2 protein was found in untreated and treated lymphomas, while the expression of protein p53 as well as MDM2 was not observed. All three types of the above-mentioned treatments (PMEDAP, DXT, DXT+PMEDAP) increased significantly the number of p21-positive cells, compared with untreated tumours.
590    __
$a bohemika - dle Pubmed
650    02
$a adenin $x analogy a deriváty $x aplikace a dávkování $7 D000225
650    02
$a zvířata $7 D000818
650    02
$a fytogenní protinádorové látky $x aplikace a dávkování $x farmakologie $x krev $7 D000972
650    12
$a protokoly protinádorové kombinované chemoterapie $x farmakologie $7 D000971
650    02
$a modely nemocí na zvířatech $7 D004195
650    02
$a synergismus léků $7 D004357
650    02
$a ženské pohlaví $7 D005260
650    02
$a injekce intraperitoneální $7 D007274
650    02
$a injekce subkutánní $7 D007279
650    12
$a lymfom T-buněčný $x farmakoterapie $7 D016399
650    02
$a mužské pohlaví $7 D008297
650    02
$a transplantace nádorů $7 D009368
650    02
$a paclitaxel $x analogy a deriváty $x aplikace a dávkování $x farmakologie $x krev $7 D017239
650    02
$a krysa rodu Rattus $7 D051381
650    02
$a potkani Sprague-Dawley $7 D017207
650    12
$a taxoidy $7 D043823
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gut, Ivan, $d 1936- $7 xx0060370 $u National Institute of Public Health, Centre of Occupational Medicine, Prague
700    1_
$a Mandys, Václav, $d 1951- $7 jn20000401720 $u Institute of Pathology, 3rd medical Faculty, Charles University; Department of Teratology, institute of Experimental Medicine, Academy of Science of the Czech Republic, Prague
700    1_
$a Holý, Antonín, $d 1936-2012 $7 jn20000401004 $u Institute of Organic Chemistry and biochemistry, Academy of Science of the Czech Republic, Prague
700    1_
$a Votruba, Ivan, $d 1942- $7 xx0030600
700    1_
$a Otová, Berta, $d 1943- $7 nlk19990073638 $u Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Prague, Czech Republic
773    0_
$t Anticancer Research $x 0250-7005 $g Roč. 21, č. 4A (2001), s. 2725-2731 $p Anticancer Res $w MED00000478
910    __
$a ABA008 $y 3 $z 0
990    __
$a 20130405105746 $b ABA008
991    __
$a 20130405114053 $b ABA008
999    __
$a ok $b bmc $g 975342 $s 810590
BAS    __
$a 3
BMC    __
$a 2001 $b 21 $c 4A $d 2725-2731 $i 0250-7005 $m Anticancer research $x MED00000478 $n Anticancer Res
GRA    __
$a NL5423 $p MZ0
LZP    __
$a NLK 2013-04/lpbo

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace